While mutations in Flot2 have not been directly implicated in monogenic nephrotic syndromes, altered expression of Flot2 has been reported in kidney diseases such as FSGS and diabetic nephropathy (10). Here, FLOT2 is linked to focal segmental glomerulosclerosis.